US Stock MarketDetailed Quotes

PBLA Panbela Therapeutics

Watchlist
  • 0.360
  • +0.030+9.09%
15min DelayTrading Dec 30 13:38 ET
1.75MMarket Cap-0.01P/E (TTM)

Panbela Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-8.68%7.17M
37.88%8.1M
38.40%6.73M
-24.77%25.65M
35.96%7.04M
116.56%7.85M
-72.39%5.88M
21.38%4.86M
240.59%34.09M
56.48%5.18M
Selling and administrative expenses
0.54%1.11M
-32.68%1.11M
-10.95%1.2M
-16.73%5.03M
-45.07%931K
-14.45%1.11M
30.60%1.64M
-24.72%1.35M
31.76%6.04M
33.36%1.7M
-General and administrative expense
0.54%1.11M
-32.68%1.11M
-10.95%1.2M
-16.73%5.03M
-45.07%931K
-14.45%1.11M
30.60%1.64M
-24.72%1.35M
31.76%6.04M
33.36%1.7M
Research and development costs
-10.19%6.05M
65.26%7M
57.41%5.52M
-26.51%20.61M
75.36%6.11M
189.35%6.74M
-78.86%4.23M
58.88%3.51M
417.22%28.05M
70.88%3.49M
Operating profit
8.68%-7.17M
-37.88%-8.1M
-38.40%-6.73M
24.77%-25.65M
-35.96%-7.04M
-116.56%-7.85M
72.39%-5.88M
-21.38%-4.86M
-240.59%-34.09M
-56.48%-5.18M
Net non-operating interest income expense
-1,909.09%-442K
-180.95%-59K
26.74%-63K
29.20%-194K
64.41%-63K
72.84%-22K
-50.00%-21K
-4,200.00%-86K
-2,390.91%-274K
-5,800.00%-177K
Non-operating interest income
--0
--0
--0
778.57%123K
125.00%9K
716.67%49K
2,350.00%49K
1,500.00%16K
1,300.00%14K
--4K
Non-operating interest expense
522.54%442K
-15.71%59K
-38.24%63K
10.07%317K
-60.22%72K
-18.39%71K
337.50%70K
3,300.00%102K
2,300.00%288K
5,933.33%181K
Other net income (expense)
2,316.67%435K
1,347.56%1.02M
-180.84%-469K
157.48%392K
0.49%614K
102.39%18K
90.33%-82K
-153.70%-167K
-13.29%-682K
6,688.89%611K
Special income (charges)
--0
--775K
----
--400K
--0
--400K
--0
----
--0
--0
-Gain on sale of property,plant,equipment
--0
--775K
----
--400K
--0
--400K
--0
----
--0
--0
Other non- operating income (expenses)
213.87%435K
402.44%248K
-180.84%-469K
98.83%-8K
0.49%614K
49.34%-382K
90.33%-82K
-153.70%-167K
-13.29%-682K
6,688.89%611K
Income before tax
8.64%-7.17M
-19.38%-7.14M
-41.95%-7.26M
27.39%-25.45M
-36.78%-6.49M
-76.09%-7.85M
73.00%-5.98M
-38.38%-5.11M
-229.94%-35.05M
-43.63%-4.75M
Income tax
0
0
-138K
-60.34%-186K
-58.33%-19K
66.07%-19K
-716.67%-147K
0
76.23%-116K
-105.15%-12K
Net income
8.42%-7.17M
-22.39%-7.14M
-39.25%-7.12M
27.68%-25.26M
-36.73%-6.47M
-77.90%-7.83M
73.64%-5.83M
-39.47%-5.11M
-244.68%-34.93M
-33.83%-4.74M
Net income continuous Operations
8.42%-7.17M
-22.39%-7.14M
-39.25%-7.12M
27.68%-25.26M
-36.73%-6.47M
-77.90%-7.83M
73.64%-5.83M
-39.47%-5.11M
-244.68%-34.93M
-33.83%-4.74M
Minority interest income
Net income attributable to the parent company
8.42%-7.17M
-22.39%-7.14M
-39.25%-7.12M
27.68%-25.26M
-36.73%-6.47M
-77.90%-7.83M
73.64%-5.83M
-39.47%-5.11M
-244.68%-34.93M
-33.83%-4.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
8.42%-7.17M
-22.39%-7.14M
-39.25%-7.12M
27.68%-25.26M
-36.73%-6.47M
-77.90%-7.83M
73.64%-5.83M
-39.47%-5.11M
-244.68%-34.93M
-33.83%-4.74M
Basic earnings per share
97.25%-1.48
99.08%-1.47
99.42%-2.28
98.42%-316.52
99.60%-13.4868
98.94%-53.74
99.38%-159.15
94.00%-392.76
-10.36%-19.97K
46.06%-3.41K
Diluted earnings per share
97.25%-1.48
99.08%-1.47
99.42%-2.28
98.42%-316.52
99.60%-13.4868
98.94%-53.74
99.38%-159.15
94.00%-392.76
-10.36%-19.97K
46.06%-3.41K
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -8.68%7.17M37.88%8.1M38.40%6.73M-24.77%25.65M35.96%7.04M116.56%7.85M-72.39%5.88M21.38%4.86M240.59%34.09M56.48%5.18M
Selling and administrative expenses 0.54%1.11M-32.68%1.11M-10.95%1.2M-16.73%5.03M-45.07%931K-14.45%1.11M30.60%1.64M-24.72%1.35M31.76%6.04M33.36%1.7M
-General and administrative expense 0.54%1.11M-32.68%1.11M-10.95%1.2M-16.73%5.03M-45.07%931K-14.45%1.11M30.60%1.64M-24.72%1.35M31.76%6.04M33.36%1.7M
Research and development costs -10.19%6.05M65.26%7M57.41%5.52M-26.51%20.61M75.36%6.11M189.35%6.74M-78.86%4.23M58.88%3.51M417.22%28.05M70.88%3.49M
Operating profit 8.68%-7.17M-37.88%-8.1M-38.40%-6.73M24.77%-25.65M-35.96%-7.04M-116.56%-7.85M72.39%-5.88M-21.38%-4.86M-240.59%-34.09M-56.48%-5.18M
Net non-operating interest income expense -1,909.09%-442K-180.95%-59K26.74%-63K29.20%-194K64.41%-63K72.84%-22K-50.00%-21K-4,200.00%-86K-2,390.91%-274K-5,800.00%-177K
Non-operating interest income --0--0--0778.57%123K125.00%9K716.67%49K2,350.00%49K1,500.00%16K1,300.00%14K--4K
Non-operating interest expense 522.54%442K-15.71%59K-38.24%63K10.07%317K-60.22%72K-18.39%71K337.50%70K3,300.00%102K2,300.00%288K5,933.33%181K
Other net income (expense) 2,316.67%435K1,347.56%1.02M-180.84%-469K157.48%392K0.49%614K102.39%18K90.33%-82K-153.70%-167K-13.29%-682K6,688.89%611K
Special income (charges) --0--775K------400K--0--400K--0------0--0
-Gain on sale of property,plant,equipment --0--775K------400K--0--400K--0------0--0
Other non- operating income (expenses) 213.87%435K402.44%248K-180.84%-469K98.83%-8K0.49%614K49.34%-382K90.33%-82K-153.70%-167K-13.29%-682K6,688.89%611K
Income before tax 8.64%-7.17M-19.38%-7.14M-41.95%-7.26M27.39%-25.45M-36.78%-6.49M-76.09%-7.85M73.00%-5.98M-38.38%-5.11M-229.94%-35.05M-43.63%-4.75M
Income tax 00-138K-60.34%-186K-58.33%-19K66.07%-19K-716.67%-147K076.23%-116K-105.15%-12K
Net income 8.42%-7.17M-22.39%-7.14M-39.25%-7.12M27.68%-25.26M-36.73%-6.47M-77.90%-7.83M73.64%-5.83M-39.47%-5.11M-244.68%-34.93M-33.83%-4.74M
Net income continuous Operations 8.42%-7.17M-22.39%-7.14M-39.25%-7.12M27.68%-25.26M-36.73%-6.47M-77.90%-7.83M73.64%-5.83M-39.47%-5.11M-244.68%-34.93M-33.83%-4.74M
Minority interest income
Net income attributable to the parent company 8.42%-7.17M-22.39%-7.14M-39.25%-7.12M27.68%-25.26M-36.73%-6.47M-77.90%-7.83M73.64%-5.83M-39.47%-5.11M-244.68%-34.93M-33.83%-4.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 8.42%-7.17M-22.39%-7.14M-39.25%-7.12M27.68%-25.26M-36.73%-6.47M-77.90%-7.83M73.64%-5.83M-39.47%-5.11M-244.68%-34.93M-33.83%-4.74M
Basic earnings per share 97.25%-1.4899.08%-1.4799.42%-2.2898.42%-316.5299.60%-13.486898.94%-53.7499.38%-159.1594.00%-392.76-10.36%-19.97K46.06%-3.41K
Diluted earnings per share 97.25%-1.4899.08%-1.4799.42%-2.2898.42%-316.5299.60%-13.486898.94%-53.7499.38%-159.1594.00%-392.76-10.36%-19.97K46.06%-3.41K
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.